Clinical Trials Directory

Trials / Completed

CompletedNCT02562547

Evaluation of the Hem-Avert® Perianal Stabilizer Into Routine Clinical Practice

Status
Completed
Phase
Study type
Observational
Enrollment
799 (actual)
Sponsor
Desert Perinatal Associates · Academic / Other
Sex
Female
Age
Healthy volunteers
Accepted

Summary

This is a retrospective data-only study following the phased introduction of the HEM-AVERT® Perianal Stabilizer into routine clinical practice. The investigators aim to capitalize on the introduction of the HEM-AVERT® Perianal Stabilizer into routine clinical practice in labor and delivery settings in the hospital of Dignity Health - St. Rose, Siena Campus and to determine whether the HEM-AVERT® Perianal Stabilizer reduces the frequency of Cesarean Section during labor and delivery.

Detailed description

The on label device in this study is the HEM-AVERT® Perianal Stabilizer manufactured by Stetrix, Inc. This study is being sponsored by Dignity Health and falls within the guidelines set forth by the Food and Drug Administration in 21 CFR Section 812.2 as a non-significant risk study. The HEM-AVERT® Perianal Stabilizer is a Class II device in accordance with FDA regulation 21 CFR 801.109. Retrospective data will be collected in this study on the reduction of c-section rates and duration of second stage of labor. These data may be used to support an application to the FDA for a new indication of reducing c-sections. It is also possible the second stage labor data may also be used in support of expanded labeling.

Conditions

Interventions

TypeNameDescription
DEVICEHem-Avert Perianal StabilizerThe HEM-AVERT® Perianal Stabilizer is an FDA approved Class II device in accordance with FDA regulations 21 CFR 801.109. The HEM-AVERT® Perianal Stabilizer is a non-invasive device used to help provide continuous pressure to the perianal region as a means to help provide support during the labor process.

Timeline

Start date
2015-04-01
Primary completion
2015-06-01
Completion
2015-09-01
First posted
2015-09-29
Last updated
2015-09-29

Source: ClinicalTrials.gov record NCT02562547. Inclusion in this directory is not an endorsement.